EHealth Awards Dec 2014 PPT Dr KA BPL Med Tech
1 like952 views
Telehealth and mHealth programs in India and South Asia are growing due to several factors: 1) Increasing rates of lifestyle diseases like cardiovascular disease and cancer due to more sedentary jobs and higher spending. 2) Demand for healthcare is increasing due to growing consumerism, insurance coverage, quality expectations, and awareness of clinical decisions. 3) mHealth solutions like BPL Medical's Lifephone Plus allow for remote monitoring of patients' ECGs and activity to provide timely medical advice and management of chronic conditions. The small, easy-to-use device connects to a smartphone app for specialists to remotely analyze readings.
EHealth Awards Dec 2014 PPT Dr KA BPL Med Tech
- 1. Telehealth and mHealth Programs in India and South Asia Dr Karthik Anantharaman Chief Marketing Officer BPL Medical Technologies (P) Ltd 1
- 2. •Source: Indian Council for Research on International Economic Relations Increase in the working class of population (30-59 years) with more sedentary jobs and higher spending capacity, will increase the incidence for lifestyle diseases such as Cardiovascular diseases and chronic disease 51% 22% 24% 42% 5% 11% 11% 14% 9% 12% 1990 2020 Deaths Communicable CVD Cancer Other NCDs Injuries •9.4 million deaths •11.4 million deaths Increase in Chronic / Lifestyle Diseases
- 3. Increasing Demand Healthcare Consumerism Insurance Coverage Increasing Awareness Quality Consciousness Better Evaluation of Clinical &Non Clinical decisions Enhance Accountability of services by providers Quality improvement & Standardization Better Technology Adaptation By Healthcare Players Preventive focus on Health Rising Income New Healthcare Service Delivery Model Source: Frost & Sullivan
- 4. Fully integrated healthcare delivery Pre 2005 Emphasis on administrative systems and automation 2015 Adoption of clinical systems Patient self management Emphasis on Home healthcare services 2020 Adoption of clinical systems Efficient Medication management Management of chronic diseases, mental health Availability of patient information for mapping disease patterns to be used in research and development of drugs and treatment techniques/technologies Patients able to self – manage disease Remote consultations and monitoring Self testing, early treatment and management of medication Greater application of bioinformatics in healthcare related research Emphasis on Home healthcare services to improve hospital efficiencies and save patient costs Private hospital groups and public hospitals integrated to deliver patient-centric healthcare services with better outreach Patient expectations of safety Safe data sharing and safe care Patient data security Patient centric healthcare delivery Patient portals, mobile technologies of patient monitoring and management 2015 2020 Opportunities in the Indian HIT Market Active use of biometrics as healthcare becomes more patient centric Optimal efficiency in healthcare delivery using IT as number of patients and costs rise Need for cost and quality transparencies will drive the use of IT in healthcare services Integrated patient records Improved Medical Tourism Healthcare IT Market Source: Frost & Sullivan
- 5. mHealth Trends 5 Today <2 years 2-5 years 5-10 years
- 7. 7
- 8. 8
- 9. 9
- 10. End User Segments for mHealth products Cardiovascular Diabetes Post Op Management Geriatric Lifestyle Emergency Public Health Preventive Health Screening
- 11. Pre-requisites for a successful mHealth company mHealth Company TPA Telco Doctor/ Hospitals Established Distribution Network Services. Scalable Network Established Manufacturing Facility Regulatory Compliance 1 2 3 5 4 End User
- 12. 12
- 13. Key Drivers & Barriers for mHealth Key Drivers Price & Value attractiveness from Consumer Technology Evolution & Mobile penetration. Rise in Incidence of life style diseases. Awareness & incomes Adoption of Patient self management & Home health services Rise in Insurance Coverage.Out-of- Pocket Payment practice Acceptance / engagement by Medical fraternity Competition on Devices & alternate models Key Barriers Revenue model from Clinician’s perspective
- 14. Product Development & Launch Roadmap Gain Credibility w/clinicians Clinical Validation, Pilot solution with Hospitals, Pan India – Customer feedback & Technology Dev, rev2 Market Release Launch, Marcom, Sales, Service of Device/Consuma ble & Back end Services. Phase 2 Dev for Clinical Trial Scale-up for Volumes Hospital Chain & Direct to Consumer alliances. Overseas GTM Product Readiness Market Survey, Pilot Production, Distribution & back-end service readiness 14
- 15. Being Healthy Begins with a Perfect Partner
- 16. A self-use, hand-held and lightweight mobile healthcare device and Cloud solution Records 12 lead ECG without patient cables & gel Easy to analyse the patient’s ECG and provides advisory quickly through a SmartPhone APP Secured personal health record maintained on Cloud Every Measurement Counts Heart Rate Activity Check ECG Monitors physical activity with a Pedometer with 3-axis sensor
- 18. ECG Recordings from BPL LifePhone PlusTM Disclaimer: ECG Quality dependent on subjective variability
- 19. Clinical Evaluation - MethodologyNumberofPatients172 Normal 57 ST Elevation MI Anterior Wall 20 Inferior Wall 25 Lateral 25 Unstable Angina 10 Tachycardia Atrial fibrillation 5 Ventricular Ectoposis 5 Sinus Tachy 5 Bradycardia 5 LBBB 5, RBBB 5 LVH 5, RVH 5, LAE/RAE 5 Others - juvenile T inversion, early repolarizations Both Blind and Revealed evaluation done. Comparison of Lifephone Plus done with 12 Lead A4 Diagnostic Hospital grade ECG machine Recordings done by patients’ self usage under supervision of the Cardiologists
- 20. Clinical Evaluation - Results
- 21. Intuitive Device Easy Workflow Small, smart and fast, the user-friendly BPL LifePhone PlusTM allows for strong patient-specialist rapport
- 22. The consumer acquires ECG, and activity. The data is transferred from the device to the smartphone through BluetoothConsumer Specialist Consumer transfers the acquired data to the specialist through a cloud server. The specialist receives the data on a specialist application The specialist analyses the user data and sends advisory through a smartphone specialist app to the consumer. The consumer receives advisory on his smartphone consumer app. He also gets a message alert
- 23. On Move On Track Activity Monitoring
- 24. The 3-axis sensor of the device provides a digital accelerometer based activity sensing support Activity Monitoring BPL LifePhone PlusTM helps the user to measure and record activities such as the distance walked, the number of steps covered, etc. Calories Burnt By monitoring different body activities instantly, BPL LifePhone PlusTM indicates the amount of calories expended. Number for calories expended gets monitored irrespective of whether the user is moving or sedentary
- 25. Dr. S S Ramesh Cardiologist, Vivus Heart Center. BPL Medical Technologies’ innovative products for mobile health check-up wherein the remote monitoring of patient is possible, enable the physician or cardiologist to see their ECG and prescribe adequate treatment. With this kind of mobile healthcare techniques introduced by BPL, the technology can be taken to the doorsteps of common man, thereby, benefitting a lot more people than ever imagined before. Dr. Raviraj V Acharya , Professor & Head of Unit VII, Kasturba MedicalCollege & Hospital BPL LifePhone PlusTM is a novel health monitoring solution and will change the way cardiology or normal healthcare is practiced. The solution is the first of its kind in the industry, which ensures the recording of 12-lead ECG with minimum possible procedures. It not only makes personal healthcare monitoring possible for patients, but also enables us to deliver speedy advisory to patients approaching us round the clock. Expert Opinion
- 26. 26 Target Customer Segments • General Practitioners • Clinics & Polyclinics • Nursing Home & Hospitals • Pharma, Corporate, Govt • Direct to Consumer • Exports Doctor/ Clinician at the heart of product positioning
- 27. 12 Lead ECG for Ambulance & Airline use
- 28. US-FDA (510K) & CE Approved
- 29. US-FDA (510K) & CE Approved
- 30. US-FDA (510K) & CE Approved
- 31. US-FDA (510K) & CE Approved
- 32. US-FDA (510K) & CE Approved
- 37. US-FDA (510K) & CE Approved
- 38. 38
- 40. Thank You